Your browser is no longer supported. Please, upgrade your browser.
Settings
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.86 Insider Own1.50% Shs Outstand148.51M Perf Week2.31%
Market Cap2.43B Forward P/E- EPS next Y-0.40 Insider Trans110.95% Shs Float142.78M Perf Month-9.61%
Income-233.80M PEG- EPS next Q-0.14 Inst Own78.30% Short Float19.73% Perf Quarter41.36%
Sales3.30M P/S736.70 EPS this Y-135.30% Inst Trans7.55% Short Ratio9.26 Perf Half Y72.86%
Book/sh0.11 P/B148.82 EPS next Y81.00% ROA-178.30% Target Price20.33 Perf Year230.04%
Cash/sh0.94 P/C17.39 EPS next 5Y- ROE391.00% 52W Range4.73 - 18.93 Perf YTD1.30%
Dividend- P/FCF- EPS past 5Y-44.67% ROI-200.90% 52W High-13.52% Beta1.51
Dividend %- Quick Ratio1.30 Sales past 5Y-37.60% Gross Margin77.00% 52W Low246.09% ATR0.94
Employees138 Current Ratio1.30 Sales Q/Q50.00% Oper. Margin- RSI (14)54.34 Volatility4.85% 5.98%
OptionableYes Debt/Eq1.15 EPS Q/Q93.00% Profit Margin- Rel Volume0.37 Prev Close16.38
ShortableYes LT Debt/Eq1.15 EarningsFeb 08 AMC Payout- Avg Volume3.04M Price16.37
Recom1.30 SMA20-0.43% SMA505.18% SMA20045.64% Volume1,134,305 Change-0.06%
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Aug-31-11Initiated Summer Street Research Buy $8
Jul-28-11Initiated Summer Street Research Buy $8
Jul-13-11Resumed Brean Murray Buy $8
May-17-11Initiated Oppenheimer Outperform $6
Feb-23-11Initiated Wedbush Outperform $6
Jul-03-07Initiated Brean Murray Buy $8
Feb-20-07Initiated Lazard Capital Buy $6
Feb-15-18 08:00AM  Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference GlobeNewswire
07:30AM  Fennec Pharma (FENC): The Most Likely Acquisition Target in Healthcare with 200-300% Upside? ACCESSWIRE
Feb-14-18 07:30AM  Blog Exposure - FDA Accepts Amicus Therapeutics NDA for Migalastat for Treatment of Fabry Disease ACCESSWIRE
Feb-13-18 03:49PM  8 Companies That Could Disappear by 2019 InvestorPlace
Feb-09-18 05:01AM  Immunomedics reports 2Q loss Associated Press
Feb-08-18 04:15PM  Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
Feb-06-18 08:00AM  Immunomedics to Report Second Quarter Fiscal 2018 Results and Host Conference Call and Webcast on February 8, 2018 GlobeNewswire
Jan-31-18 08:20AM  New Research: Key Drivers of Growth for Cavco Industries, National Commerce, The Providence Service, Cisco, Immunomedics, and Emergent Biosolutions Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-17-18 07:00AM  Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock InvestorPlace
Jan-11-18 08:00AM  Immunomedics Announces Agreement with University of Wisconsin Carbone Cancer Center to Expand Sacituzumab Govitecan (IMMU-132) into Prostate Cancer GlobeNewswire
Jan-10-18 08:00AM  Todays Research Reports on Stocks to Watch: Immunomedics, Inc. and Axsome Therapeutics ACCESSWIRE
Jan-08-18 08:30AM  Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 Million GlobeNewswire
Jan-04-18 08:45AM  Immunomedics to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 11:34AM  Harry Boxer: These two marijuana stocks are climbing higher MarketWatch
Dec-22-17 11:41AM  ETFs with exposure to Immunomedics, Inc. : December 22, 2017 Capital Cube +6.08%
Dec-21-17 12:23PM  BlackBerry Among Four Stocks Breaking Out Forbes
Dec-13-17 07:02AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Immunomedics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Dec-11-17 01:59PM  ETFs with exposure to Immunomedics, Inc. : December 11, 2017 Capital Cube
Dec-08-17 01:59PM  5 Cheap Biotech Stocks to Snag on the Bounce InvestorPlace
07:45AM  Immunomedics' Data Is Good News for Seattle Genetics, Too Motley Fool
07:16AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : December 8, 2017 Capital Cube
Dec-07-17 08:10AM  Todays Research Reports on Stocks to Watch: Immunomedics and Valeant Pharmaceuticals ACCESSWIRE +16.16%
Dec-06-17 03:58PM  Why Immunomedics, Inc. Is Soaring Today Motley Fool +13.00%
12:10PM  Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) In Patients With Relapsed Or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC) GlobeNewswire
Nov-30-17 02:00PM  ETFs with exposure to Immunomedics, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:04AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017 Capital Cube
Nov-28-17 08:05AM  Immunomedics, Full Study Data to be Presented December 6, 2017, BLA Application as Early as 1Q18 ACCESSWIRE
Nov-27-17 08:05AM  Analysis: Positioning to Benefit within Aradigm, General Motors, AT&T, Denbury Resources, Novavax, and Immunomedics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-20-17 07:40AM  Featured Company News - Biohaven Pharma Completed Enrollment in First of Two Pivotal Phase-3 Clinical Trials of Rimegepant for Acute Treatment of Migraine ACCESSWIRE
Nov-16-17 08:43AM  Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock Zacks +8.11%
Nov-15-17 08:38AM  Immunomedics (IMMU) Jumps: Stock Rises 5.4% Zacks +5.31%
Nov-14-17 04:07PM  Edited Transcript of IMMU earnings conference call or presentation 9-Nov-17 10:00pm GMT Thomson Reuters StreetEvents +5.40%
12:44PM  Cowen Bets on Immunomedics Securing Accelerated Approval Even After Decreased Overall Survival Seen in IMMU-132 Abstract SmarterAnalyst
Nov-13-17 04:30PM  Why Sears Holdings, Immunomedics, and J.C. Penney Slumped Today Motley Fool -19.35%
09:30AM  Immunomedics Announces Presentations and Investor Event at the 2017 San Antonio Breast Cancer Symposium GlobeNewswire
07:24AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : November 13, 2017 Capital Cube
Nov-10-17 03:02PM  Why Immunomedics, Inc. Jumped Higher Today Motley Fool +18.77%
08:20AM  Todays Research Reports on Trending Tickers: Endo International and Immunomedics ACCESSWIRE
Nov-09-17 05:21PM  Immunomedics reports 1Q loss Associated Press
04:10PM  Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
04:05PM  Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth GlobeNewswire
01:00PM  Immunomedics, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-17 08:00AM  Immunomedics to Report First Quarter Fiscal 2018 Results and Host Conference Call and Webcast on November 9, 2017 GlobeNewswire +6.82%
Oct-31-17 12:13PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : October 31, 2017 Capital Cube -5.13%
11:42AM  ETFs with exposure to Immunomedics, Inc. : October 31, 2017 Capital Cube
Oct-30-17 08:11AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : October 30, 2017 Capital Cube
Oct-27-17 09:35AM  Versartis Drops on Q3 Numbers, Hires Adviser -- Biotech Movers TheStreet.com +6.18%
Oct-23-17 08:37AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Oct-05-17 12:21PM  Edited Transcript of IMMU earnings conference call or presentation 16-Aug-17 9:00pm GMT Thomson Reuters StreetEvents -8.50%
Oct-03-17 11:19AM  ETFs with exposure to Immunomedics, Inc. : October 3, 2017 Capital Cube
Sep-15-17 04:30PM  Why Carnival, Immunomedics, and Fitbit Slumped Today Motley Fool
08:00AM  Immunomedics Announces Agreements to Exchange Approximately $80.0 Million of Its 4.75% Convertible Senior Notes Due 2020 for Common Stock GlobeNewswire
Sep-11-17 09:00AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks +5.17%
07:00AM  Immunomedics Presents Interim Phase 2 Results With Sacituzumab Govitecan (IMMU-132) in Patients With Pretreated Metastatic Urothelial Cancer GlobeNewswire
Aug-30-17 08:00AM  Immunomedics to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-28-17 05:33PM  ETFs with exposure to Immunomedics, Inc. : August 28, 2017 Capital Cube +14.07%
03:30PM  Here's Why Immunomedics Rose as Much as 14.2% Today Motley Fool
Aug-24-17 12:51PM  Harry Boxer: These three biotech stocks are breaking out MarketWatch +9.88%
10:45AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q4, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-23-17 08:48AM  Immunomedics (IMMU) Catches Eye: Stock Up 5.1% Zacks
08:41AM  Zacks.com featured highlights: Glu Mobile, Calumet Specialty Products Partners, The Bancorp, Immunomedics and Hudbay Minerals Zacks
Aug-22-17 10:44AM  Immunomedics' Progress in Phase II Cancer Study Encouraging Zacks +5.11%
08:23AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : August 22, 2017 Capital Cube
Aug-21-17 02:02PM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: 2017 By the Numbers : August 21, 2017 Capital Cube +7.01%
08:00AM  Immunomedics Announces Publication of Phase 2 Results With Labetuzumab Govitecan (IMMU-130) That Demonstrate Promising Efficacy as a Single Agent in Patients With Metastatic Colorectal Cancer GlobeNewswire
Aug-17-17 08:50AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Aug-16-17 09:21PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : August 17, 2017 Capital Cube
09:14PM  Immunomedics reports 4Q loss Associated Press
04:00PM  Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline GlobeNewswire
Aug-07-17 04:00PM  Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2017 Results GlobeNewswire
Aug-03-17 09:46AM  Immunomedics, Inc. breached its 50 day moving average in a Bearish Manner : IMMU-US : August 3, 2017 Capital Cube
Jul-10-17 02:40PM  ETFs with exposure to Immunomedics, Inc. : July 10, 2017 Capital Cube
09:00AM  Published Results from Clinical Trials Demonstrate Therapeutic Potential for Immunomedics Sacituzumab Govitecan (IMMU-132) in the Treatment of Metastatic Solid Cancers GlobeNewswire
Jun-29-17 03:11PM  Immunomedics Announces Results of Special Stockholder Meeting GlobeNewswire
08:35AM  Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock Zacks
Jun-27-17 03:20PM  ETFs with exposure to Immunomedics, Inc. : June 27, 2017 Capital Cube
Jun-16-17 03:54PM  ETFs with exposure to Immunomedics, Inc. : June 16, 2017 Capital Cube
Jun-07-17 11:05AM  Three Junior Biotechs Ready to Run Investopedia
Jun-05-17 02:22PM  ETFs with exposure to Immunomedics, Inc. : June 5, 2017 Capital Cube
Jun-01-17 08:00AM  Immunomedics to Present at Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-26-17 09:33AM  Biotech Movers: Immunomedics, Aerie, Exelixis TheStreet.com
May-25-17 12:41PM  ETFs with exposure to Immunomedics, Inc. : May 25, 2017 Capital Cube
May-24-17 09:51AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017 Capital Cube
May-18-17 05:00AM  Edited Transcript of IMMU earnings conference call or presentation 10-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-11-17 09:21PM  Edited Transcript of IMMU earnings conference call or presentation 10-May-17 9:00pm GMT Thomson Reuters StreetEvents +6.14%
May-10-17 04:10PM  Immunomedics reports 3Q loss Associated Press
04:00PM  Immunomedics Announces Third Quarter Fiscal 2017 Results and Clinical Program Developments GlobeNewswire
08:15AM  Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2017 Results GlobeNewswire
May-08-17 05:53PM  The Head-Scratching Reason Immunomedics Rose by as Much as 12% Motley Fool +8.02%
08:25AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : May 8, 2017 Capital Cube
08:00AM  Today's Research Report on Biotech Stocks to Watch: Immunomedics and Esperion Therapeutics Accesswire
06:00AM  Immunomedics Breaks Out, But Will It Last? Investopedia
May-06-17 09:10AM  Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated? 24/7 Wall St.
May-05-17 04:32PM  Immunomedics, Seattle Genetics Scrap License Deal TheStreet.com +17.56%
04:22PM  Why Immunomedics, MercadoLibre, and Pearson Jumped Today Motley Fool
01:57PM  Why Immunomedics, Inc. Rocketed Today Motley Fool
10:42AM  Biotech Movers: Immunomedics Shares Jump After License Pact with Seattle Genetics Is Terminated TheStreet.com
08:46AM  Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value Business Wire
Apr-25-17 04:18PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : April 25, 2017 Capital Cube +6.98%
Apr-24-17 08:41AM  Immunomedics, Inc. breached its 50 day moving average in a Bearish Manner : IMMU-US : April 24, 2017 Capital Cube
Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and IMMU-140 that targets HLA-DR for the potential treatment of liquid cancers. It also develops products for the treatment of cancer and autoimmune diseases, including epratuzumab, anti-CD22 antibody; veltuzumab, anti-CD20 antibody; milatuzumab, anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. The company also provides LeukoScan, a diagnostic imaging product to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody; and a collaboration agreement with University of Wisconsin Carbone Cancer Center to expand IMMU-132 into prostate cancer. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARKISON BRIAN ADirectorNov 20Option Exercise3.1615,00047,40099,178Nov 21 05:00 PM
MARKISON BRIAN ADirectorNov 20Sale11.898,39099,72490,788Nov 21 05:00 PM
venBio Select Advisor LLCDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 15 05:48 PM
venBio Select Advisor LLCDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 15 05:48 PM
GOLDENBERG CYNTHIA LDirectorSep 01Sale12.9010,000129,000778,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksSep 01Sale12.9010,000129,0003,395,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 31Sale12.3810,000123,750788,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksAug 31Sale12.3810,000123,7503,405,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 28Sale11.5215,000172,841798,219Aug 28 08:54 PM
GOLDENBERG DAVID MSee RemarksAug 28Sale11.5610,000115,5913,415,578Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 24Sale10.2425,000256,105813,219Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 23Sale9.5010,00095,000838,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 23Sale9.5010,00095,0003,455,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 22Sale9.5010,00095,000848,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 22Sale9.5010,00095,0003,465,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 21Sale8.9720,000179,426858,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 21Sale8.9720,000179,4263,475,578Aug 23 09:00 PM
CONN Conn's, Inc. daily Stock Chart
CONN [NASD]
Conn's, Inc.
Index- P/E316.50 EPS (ttm)0.10 Insider Own2.20% Shs Outstand31.86M Perf Week-0.47%
Market Cap1.01B Forward P/E13.08 EPS next Y2.42 Insider Trans-67.70% Shs Float18.14M Perf Month-14.92%
Income3.20M PEG13.76 EPS next Q0.54 Inst Own68.90% Short Float25.01% Perf Quarter3.43%
Sales1.53B P/S0.66 EPS this Y-195.70% Inst Trans-3.48% Short Ratio9.14 Perf Half Y69.25%
Book/sh16.92 P/B1.87 EPS next Y159.38% ROA0.20% Target Price39.00 Perf Year213.37%
Cash/sh0.40 P/C79.40 EPS next 5Y23.00% ROE0.60% 52W Range7.75 - 37.80 Perf YTD-10.97%
Dividend- P/FCF11.43 EPS past 5Y-48.00% ROI4.40% 52W High-16.27% Beta1.81
Dividend %- Quick Ratio3.00 Sales past 5Y15.00% Gross Margin51.80% 52W Low308.39% ATR1.69
Employees4000 Current Ratio3.90 Sales Q/Q-1.00% Oper. Margin6.30% RSI (14)46.16 Volatility4.71% 5.52%
OptionableYes Debt/Eq1.96 EPS Q/Q139.90% Profit Margin0.20% Rel Volume0.51 Prev Close31.05
ShortableYes LT Debt/Eq1.84 EarningsMar 08 BMO Payout0.00% Avg Volume496.57K Price31.65
Recom1.80 SMA20-1.93% SMA50-6.59% SMA20023.95% Volume253,267 Change1.93%
Oct-18-17Reiterated KeyBanc Capital Mkts Overweight $24 → $42
Oct-09-17Downgrade Stifel Buy → Hold $26 → $30
Sep-08-17Reiterated Stifel Buy $20 → $26
Jun-07-17Reiterated Stifel Buy $19 → $20
Apr-26-17Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Sep-21-16Upgrade Stifel Hold → Buy $16
Jun-03-16Downgrade Piper Jaffray Overweight → Neutral
Jan-13-16Downgrade Stifel Buy → Hold
Dec-09-15Reiterated Stifel Buy $35 → $32
Dec-01-15Upgrade Stifel Hold → Buy $35
Sep-15-15Downgrade Stifel Buy → Hold
Jun-03-15Reiterated Stifel Buy $43 → $49
May-22-15Reiterated Stifel Buy $35 → $43
May-11-15Reiterated Piper Jaffray Overweight $38 → $45
May-05-15Upgrade Oppenheimer Perform → Outperform $39
Feb-09-15Upgrade Stifel Hold → Buy $33
Dec-10-14Reiterated B. Riley & Co. Buy $62 → $52
Sep-03-14Reiterated Canaccord Genuity Buy $71 → $40
Sep-03-14Downgrade Stifel Buy → Hold
Jun-03-14Reiterated Stifel Buy $51 → $61
Feb-22-18 08:40AM  The Zacks Analyst Blog Highlights: Kohl's, Best Buy, Conn's, RH and Walmart Zacks
Feb-13-18 12:59PM  W.R. Grace & Co.-Conn. -- Moody's assigns Ba1 ratings to Grace's new $1.3 billion secured credit facilities Moody's
Jan-19-18 09:12AM  New Strong Buy Stocks for January 19th Zacks
Jan-16-18 08:01PM  Edited Transcript of CONN earnings conference call or presentation 7-Dec-17 4:00pm GMT Thomson Reuters StreetEvents -6.73%
07:49AM  Factors That Make Beacon Roofing (BECN) a Lucrative Bet Now Zacks
Jan-10-18 07:53AM  The Zacks Analyst Blog Highlights: Conn's, Beacon Roofing, McDonald's and Boot Barn Zacks
Jan-09-18 06:59PM  Cramer's lightning round: The analysts downgrading Edward... CNBC Videos
07:40AM  Free Research Report as Conns Q3 Results Outshone Expectations ACCESSWIRE
Jan-04-18 07:30AM  New Research: Key Drivers of Growth for Conn's, Molina Healthcare, Zillow Group, Boston Properties, BWX Technologies, and Penumbra Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-02-18 02:19PM  Stephens' Analysts Present Their Best Ideas For 2018 Benzinga
Dec-29-17 08:30AM  Conn's (CONN): Strong Industry, Solid Earnings Estimate Revisions Zacks
Dec-28-17 07:10AM  Free Post Earnings Research Report: Best Buy's Revenue Grew 4%; EPS Surged 30% ACCESSWIRE
Dec-27-17 04:17PM  Stephens Drops 18 Names From Best Ideas List Before The New Year Benzinga
08:34AM  Retail is Staging a Big Comeback in 2018: 5 Solid Buys Zacks
08:34AM  7 Hot Momentum Stocks to Watch in 2018 Zacks
Dec-26-17 11:23AM  ETFs with exposure to Conns, Inc. : December 26, 2017 Capital Cube
Dec-21-17 08:52AM  Surging Earnings Estimates Signal Good News for Conn's (CONN) Zacks
Dec-20-17 05:00PM  Conn's, Inc. Announces Closing of $669.3 Million Securitization Transaction GlobeNewswire
Dec-13-17 07:30PM  Conn's, Inc. Announces Pricing of Securitization Transaction GlobeNewswire
09:39AM  Top Ranked Momentum Stocks to Buy for December 13th Zacks
Dec-12-17 12:59PM  ETFs with exposure to Conns, Inc. : December 12, 2017 Capital Cube
Dec-11-17 10:42AM  Conns, Inc. :CONN-US: Earnings Analysis: Q3, 2018 By the Numbers : December 11, 2017 Capital Cube -5.71%
Dec-08-17 10:14AM  Company News For Dec 8, 2017 Zacks
08:58AM  Conn's (CONN) in Focus: Stock Moves 6.2% Higher Zacks
Dec-07-17 01:29PM  Shares of Conn's Bounce 16% After 2nd Consecutive Profitable Quarter Motley Fool +6.19%
08:00AM  Conn's, Inc. to Host Earnings Call ACCESSWIRE
06:19AM  Conn's beats Street 3Q forecasts Associated Press
06:00AM  Conn's, Inc. Reports Third Quarter Fiscal Year 2018 Financial Results GlobeNewswire
Dec-06-17 06:12PM  Initial claims, Dollar General What you need to know in markets on Thursday Yahoo Finance
Nov-30-17 05:07PM  Conn's, Inc. Schedules Conference Call to Discuss Third-Quarter Fiscal 2018 Results GlobeNewswire
Nov-27-17 10:42AM  Black Friday 2017: Here Are The Retailers Who Showed Holiday Promise Benzinga
Nov-08-17 02:37PM  7 Large-Cap Stocks With a Potential Financial Dark Side InvestorPlace
Oct-30-17 10:38AM  US GDP Hits 3% Despite Twin Hurricanes: 5 Top Gainers Zacks
10:11AM  Aaron's (AAN) Stock Falls on Q3 Earnings Miss, Revenues Beat Zacks
Oct-26-17 05:00PM  Does Conns Incs (CONN) Debt Level Pose A Serious Problem? Simply Wall St.
10:10AM  Tractor Supply (TSCO) Beats on Q3 Earnings, Raises Guidance Zacks
Oct-25-17 11:12AM  Harry Boxers momentum stocks to watch this week MarketWatch
Oct-24-17 04:30PM  Why Polaris Industries, Corning, and Conn's Jumped Today Motley Fool +16.57%
01:37PM  Shares of Conn's Move 10% Higher After Sales Uptick Motley Fool
12:33PM  3 Stocks Where Shrinking Revenue Is No Big Deal Motley Fool
Oct-23-17 05:24PM  Conn's, Inc. Provides Business Update Post Hurricane Harvey and Third Quarter Guidance GlobeNewswire
Oct-20-17 09:55AM  Conn's, Titan International and PayPal Holdings highlighted as Zacks Bull and Bear of the Day Zacks
07:01AM  Bull of the Day: Conn's Inc. (CONN) Zacks
Oct-12-17 07:49AM  5 Stocks With Strong Earnings Beat Potential Zacks
Oct-10-17 11:12AM  ETFs with exposure to Conns, Inc. : October 10, 2017 Capital Cube
08:47AM  Why You Shouldn't Bet Against Conn's (CONN) Stock Zacks
Oct-09-17 05:17PM  Furniture Stores Show September Stock Gains Motley Fool -6.08%
Oct-06-17 08:38AM  Are Options Traders Betting on a Big Move in Conn's (CONN) Stock? Zacks
Oct-04-17 09:03AM  Zacks.com featured highlights include article EVERTEC, Amphenol, Stanley Black & Decker and Conn's Zacks
Oct-03-17 03:42PM  Can Conn's Stock Keep Going After Last Week's 23% Pop? Motley Fool
Sep-29-17 08:52AM  Conn's stock jumps toward 21-month high after an analyst upgrade MarketWatch +9.75%
08:32AM  Should You Be Concerned About Conns Incs (CONN) Risks? Simply Wall St.
Sep-28-17 07:30AM  Earnings Review and Free Research Report: Conn's Reported Better than Expected Earnings ACCESSWIRE
Sep-27-17 04:07PM  Conn's and Signet are Aggressive Growth Rank Buys Zacks
Sep-26-17 10:46AM  ETFs with exposure to Conns, Inc. : September 26, 2017 Capital Cube
Sep-18-17 08:16AM  Conns HomePlus Introduces National Toy and Book Drive to Support Texas Children Impacted by Hurricane Harvey Business Wire
Sep-16-17 09:20AM  These 3 Stocks Have Doubled Investors' Money Motley Fool
Sep-15-17 08:38AM  Options Traders Expect Huge Moves in Conn's (CONN) Stock Zacks
Sep-13-17 05:50PM  ETFs with exposure to Conns, Inc. : September 13, 2017 Capital Cube
Sep-11-17 03:12PM  Conns, Inc. :CONN-US: Earnings Analysis: Q2, 2018 By the Numbers : September 11, 2017 Capital Cube
11:56AM  Edited Transcript of CONN earnings conference call or presentation 7-Sep-17 3:00pm GMT Thomson Reuters StreetEvents
08:57AM  Conn's (CONN) in Focus: Stock Moves 6.2% Higher Zacks
Sep-08-17 10:10AM  Company News For Sep 8, 2017 Zacks +6.21%
Sep-07-17 09:22PM  Conn's beats 2Q profit forecasts Associated Press +14.17%
02:15PM  Francesca's, Conn's expect a drop in sales after Harvey's devastation American City Business Journals
07:20AM  Investor Network: Conn's, Inc. to Host Earnings Call ACCESSWIRE
06:00AM  Conn's, Inc. Reports Second Quarter Fiscal Year 2018 Financial Results Business Wire
Sep-05-17 03:43PM  Conn's Stock Hopes to Avoid Best Buy's Trap on Thursday Motley Fool
09:41AM  What's in the Cards for Conn's (CONN) This Earnings Season? Zacks
Sep-01-17 04:59PM  Why L Brands, Conn's, and lululemon athletica Jumped Today Motley Fool +12.10%
10:15AM  Conn's, Inc. Reports Status of Business after Hurricane Harvey and Announces $200,000 Donation Matching Program to Support Affected Employees and Local Communities Business Wire
Aug-31-17 07:14PM  Conn's, Inc. Schedules Conference Call to Discuss Second-Quarter Fiscal 2018 Results Business Wire
Aug-28-17 08:16PM  Conns, Inc. Value Analysis (NASDAQ:CONN) : August 29, 2017 Capital Cube
Aug-18-17 10:11AM  Conns, Inc. breached its 50 day moving average in a Bearish Manner : CONN-US : August 18, 2017 Capital Cube
Aug-10-17 05:58PM  Wells Fargo Commercial Mortgage Trust 2015-NXS3 -- Moody's Affirms Six Classes of WFCM 2015-NXS3 Moody's -5.15%
Aug-05-17 08:10AM  Forget American Outdoor Brands Corp.: These 3 Stocks Doubled Last Year Motley Fool
Aug-01-17 05:33PM  These 5 Retailers May Not Survive 2017 Motley Fool
08:51AM  Short Story from Briefing.com Briefing.com
Jul-31-17 10:15AM  Aaron's (AAN) Q2 Earnings & Sales Beat Estimates, Stock Up Zacks -5.31%
Jul-28-17 07:49AM  Can the Rally in Conn's (CONN) Shares Continue? Zacks
Jul-26-17 09:30AM  Zacks Investment Ideas feature highlights: Amazon, Best Buy, Aaron's and Conn's Zacks
Jul-25-17 01:57PM  Not All Retail Stocks Will Be Crushed By Amazon Zacks
Jun-29-17 03:47PM  5 Retail Growth Stocks To Buy Now Zacks +5.87%
08:43AM  Others Overlooked Conn's, Inc. (CONN), Should You Buy It Now? Zacks
Jun-28-17 10:39AM  Big Lots Down 5% in Six Months: Can it Bounce Back in 2H17? Zacks
Jun-23-17 05:26PM  Steve Cohen's Point72 Takes Stake in Struggling Electronics Retailer Conn's TheStreet.com
Jun-22-17 08:57AM  How Conn's (CONN) Stock Stands Out in a Strong Industry Zacks
Jun-20-17 08:15AM  Earnings Highlights and Review: GameStop's Q1 Results Topped Estimates Accesswire -6.60%
Jun-19-17 03:06PM  ETFs with exposure to Conns, Inc. : June 19, 2017 Capital Cube +6.76%
08:38AM  Earnings Estimates Moving Higher for Conn's (CONN): Time to Buy? Zacks
Jun-13-17 04:03PM  Top 10 Stocks Under $20 Zacks
Jun-09-17 01:22PM  ETFs with exposure to Conns, Inc. : June 9, 2017 Capital Cube
Jun-08-17 10:21AM  Conns, Inc. :CONN-US: Earnings Analysis: Q1, 2018 By the Numbers : June 8, 2017 Capital Cube
Jun-07-17 10:29AM  Stock Market News for June 07, 2017 Zacks +9.91%
09:44AM  Conn's (CONN) Q1 Loss Narrower than Expected, Stock Tumbles Zacks
07:30AM  Conn's Shares Fall After it Fails to Impress in Q1 (CONN) Investopedia
Jun-06-17 10:15PM  Edited Transcript of CONN earnings conference call or presentation 6-Jun-17 3:00pm GMT Thomson Reuters StreetEvents -9.14%
03:58PM  Why Shares of Conn's Dropped Today Motley Fool
10:00AM  Investor Network: Conn's, Inc. to Host Earnings Call Accesswire
08:55AM  Why Conns Bottom-Line Beat Was Not Enough for Investors 24/7 Wall St.
Conn's, Inc. operates as a specialty retailer of durable consumer goods and related services in the United States. It operates through two segments, Retail and Credit. The company's stores provide furniture and mattress, including furniture and related accessories for the living room, dining room, and bedroom, as well as traditional and specialty mattresses; home appliances comprising refrigerators, freezers, washers, dryers, dishwashers, and ranges; and home office products consisting of computers, printers, and accessories. Its stores also offer consumer electronics, such as LED, OLED, Ultra HD, and Internet-ready televisions; and Blu-ray players, and home theater and portable audio equipment. The company also provides short- and medium-term financing to its retail customers, as well as offers product support services, such as product repair services, repair service agreements, and various credit insurance products. As of January 31, 2017, it operated 113 retail locations in Alabama, Arizona, Colorado, Georgia, Louisiana, Mississippi, Nevada, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas. Conn's, Inc. was founded in 1890 and is based in The Woodlands, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anchorage Capital Group, L.L.C10% OwnerDec 18Sale34.051,600,00054,480,0002,953,958Dec 20 04:51 PM
Schofman DavidDirectorDec 11Buy32.201,00032,19820,384Dec 14 05:27 PM
STEPHENS WARREN A10% OwnerOct 16Buy25.5023,000586,4752,792,920Oct 18 05:42 PM
STEPHENS HARRIET C10% OwnerOct 16Buy25.5023,000586,4752,792,920Oct 18 05:40 PM
STEPHENS WARREN A10% OwnerOct 13Buy25.5012,000306,0222,769,920Oct 16 05:58 PM
STEPHENS HARRIET C10% OwnerOct 13Buy25.5012,000306,0222,769,920Oct 16 05:57 PM
STEPHENS WARREN A10% OwnerOct 12Buy25.3630,000760,7792,757,920Oct 16 05:58 PM
STEPHENS HARRIET C10% OwnerOct 12Buy25.3630,000760,7792,757,920Oct 16 05:57 PM
Stephens W. R. Jr.10% OwnerJul 14Buy18.8512,000226,176152,645Jul 18 04:12 PM
Renaud ToddVice President - CIOJun 19Sale19.001,00019,00050,697Jun 20 01:09 PM
HAWORTH JAMES HDirectorJun 12Sale19.347,392142,9614,425Jun 13 07:06 PM
MARTIN DOUGLAS HDirectorJun 07Buy17.8310,000178,27238,827Jun 09 05:36 PM
Daly BrianChief Human Resources OfficerApr 20Buy13.527,400100,04826,652Apr 21 03:30 PM
LPTH LightPath Technologies, Inc. daily Stock Chart
LPTH [NASD]
LightPath Technologies, Inc.
Index- P/E6.84 EPS (ttm)0.32 Insider Own3.50% Shs Outstand24.96M Perf Week-9.24%
Market Cap53.91M Forward P/E13.94 EPS next Y0.16 Insider Trans0.00% Shs Float20.84M Perf Month-17.87%
Income7.80M PEG- EPS next Q0.02 Inst Own27.60% Short Float6.88% Perf Quarter-13.25%
Sales30.90M P/S1.74 EPS this Y324.10% Inst Trans-12.15% Short Ratio5.07 Perf Half Y-12.20%
Book/sh1.32 P/B1.64 EPS next Y106.67% ROA- Target Price2.77 Perf Year-5.68%
Cash/sh0.31 P/C7.00 EPS next 5Y- ROE- 52W Range2.03 - 4.10 Perf YTD-2.70%
Dividend- P/FCF29.95 EPS past 5Y43.40% ROI27.20% 52W High-47.30% Beta-0.40
Dividend %- Quick Ratio2.70 Sales past 5Y20.20% Gross Margin49.00% 52W Low6.40% ATR0.12
Employees321 Current Ratio3.90 Sales Q/Q42.40% Oper. Margin- RSI (14)42.40 Volatility5.01% 5.66%
OptionableNo Debt/Eq0.34 EPS Q/Q-61.40% Profit Margin- Rel Volume0.59 Prev Close2.18
ShortableYes LT Debt/Eq0.30 EarningsFeb 21 AMC Payout0.00% Avg Volume282.53K Price2.16
Recom1.50 SMA20-6.59% SMA50-7.22% SMA200-18.84% Volume166,000 Change-0.92%
Oct-06-17Resumed Dougherty & Company Buy $3.10
May-05-17Reiterated Dougherty & Company Buy $3 → $3.50
Jan-10-17Initiated Dougherty & Company Buy $2.50
Dec-22-16Initiated ROTH Capital Buy $2.50
Feb-22-18 08:30AM  LightPath Technologies to Present at 30th Annual ROTH Conference ACCESSWIRE
Feb-13-18 04:00PM  LightPath Technologies Reports 42% Increase in Revenue for Fiscal 2018 Second Quarter Financial Results ACCESSWIRE
12:15PM  LightPath Technologies, Inc. Class A to Host Earnings Call ACCESSWIRE
Feb-09-18 07:45AM  Research Report Identifies Hill-Rom, Quantum, Heron Therapeutics, Dillard's, LightPath Technologies, and Adesto Technologies with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-06-18 08:30AM  LightPath Technologies Schedules Fiscal 2018 Second Quarter Financial Results Conference Call for February 13 ACCESSWIRE
Feb-05-18 04:46PM  5 of the Best Stocks Under $10 for 2018 Zacks
Feb-01-18 06:00AM  Avidbank Provides $8.3 Million Credit Facilities to LightPath Technologies Business Wire
Jan-25-18 09:00AM  LightPath Technologies Exhibiting at the World's Largest Photonics Technologies Event, SPIE Photonics West 2018 ACCESSWIRE
Jan-16-18 04:00PM  LightPath Restructures Debt with Net Debt Reduced by 32% ACCESSWIRE
Jan-09-18 08:30AM  LightPath to Participate in Needham Growth Conference on January 17, 2018 in New York ACCESSWIRE
Jan-03-18 10:35AM  LightPath Technologies Receives $5 Million Order for Infrared Optical Lens Elements ACCESSWIRE +5.22%
Dec-29-17 12:18PM  ETFs with exposure to LightPath Technologies, Inc. : December 29, 2017 Capital Cube
Dec-18-17 03:53PM  ETFs with exposure to LightPath Technologies, Inc. : December 18, 2017 Capital Cube
Dec-08-17 01:09PM  ETFs with exposure to LightPath Technologies, Inc. : December 8, 2017 Capital Cube
Dec-07-17 10:06AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q1, 2018 By the Numbers : December 7, 2017 Capital Cube
Dec-06-17 08:30AM  LightPath Technologies Bolsters Automotive Electronics Capabilities ACCESSWIRE
Nov-29-17 08:30AM  LightPath Technologies Expands Manufacturing Facility in Latvia to Accommodate Continued Growth for Infrared Products ACCESSWIRE
Nov-21-17 06:29PM  Should You Expect LightPath Technologies Inc (LPTH) To Continue Delivering An ROE Of 37.47%? Simply Wall St.
Nov-20-17 08:10AM  Recent Analysis Shows Premier, Quantum, Heron Therapeutics, Dillard's, LightPath Technologies, and Ichor Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-10-17 12:40PM  ETFs with exposure to LightPath Technologies, Inc. : November 10, 2017 Capital Cube -22.19%
Nov-09-17 10:51PM  Edited Transcript of LPTH earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
04:00PM  LightPath Technologies Reports 51% Increase in Revenue for Fiscal 2018 First Quarter Financial Results ACCESSWIRE
12:30PM  LightPath Technologies, Inc. Class A to Host Earnings Call ACCESSWIRE
Oct-31-17 10:12AM  Penny Stocks to Watch for November 2017 Investopedia
Oct-27-17 11:03AM  ETFs with exposure to LightPath Technologies, Inc. : October 27, 2017 Capital Cube
Oct-26-17 10:01AM  LightPath Technologies, Inc.: Leads amongst peers with strong fundamentals Capital Cube +8.21%
08:55AM  LightPath Technologies (LPTH) Surges: Stock Moves 14.8% Higher Zacks
Oct-19-17 09:15AM  LightPath Technologies Schedules Fiscal 2018 First Quarter Financial Results Conference Call for November 9 ACCESSWIRE
Oct-17-17 09:50AM  ETFs with exposure to LightPath Technologies, Inc. : October 17, 2017 Capital Cube
Oct-06-17 10:56AM  ETFs with exposure to LightPath Technologies, Inc. : October 6, 2017 Capital Cube
Oct-02-17 07:50AM  Earnings Review and Free Research Report: LightPath Technologies Revenue Soared 90%; EPS Rocketed 1100% ACCESSWIRE
Sep-26-17 10:56AM  ETFs with exposure to LightPath Technologies, Inc. : September 26, 2017 Capital Cube
Sep-19-17 11:45AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q4, 2017 By the Numbers : September 19, 2017 Capital Cube
Sep-18-17 02:59PM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: 2017 By the Numbers : September 18, 2017 Capital Cube
Sep-15-17 07:13PM  LightPath Technologies Up on Earnings Beat GuruFocus.com +8.30%
05:41PM  ETFs with exposure to LightPath Technologies, Inc. : September 15, 2017 Capital Cube
09:40AM  Edited Transcript of LPTH earnings conference call or presentation 14-Sep-17 8:30pm GMT Thomson Reuters StreetEvents
Sep-14-17 04:15PM  LightPath Technologies Reports 117% Increase in Operating Income for Fiscal 2017 Fourth Quarter Financial Results ACCESSWIRE -6.59%
12:00PM  Investor Network: LightPath Technologies, Inc. Class A to Host Earnings Call ACCESSWIRE
Sep-11-17 07:19AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating LightPath Technologies, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire -7.06%
Sep-05-17 12:00PM  CORRECTION: LightPath Technologies to Participate in Dougherty & Co. Institutional Investor Conference on September 19, 2017 in Minneapolis ACCESSWIRE
09:00AM  LightPath Technologies to Participate in Dougherty & Co. Institutional Investor Conference on September 20, 2017 in Minneapolis ACCESSWIRE
Aug-10-17 04:05PM  LightPath Technologies Announces Preliminary Results for Fiscal 2017 Fourth Quarter ACCESSWIRE
Aug-01-17 04:52PM  ETFs with exposure to LightPath Technologies, Inc. : August 1, 2017 Capital Cube
Jul-06-17 01:58PM  ETFs with exposure to LightPath Technologies, Inc. : July 6, 2017 Capital Cube
Jun-26-17 09:29AM  LightPath Technologies Added to the Russell Microcap(R) Index Accesswire
Jun-19-17 03:40PM  ETFs with exposure to LightPath Technologies, Inc. : June 19, 2017 Capital Cube +5.64%
Jun-05-17 02:29PM  ETFs with exposure to LightPath Technologies, Inc. : June 5, 2017 Capital Cube
Jun-02-17 09:00AM  LightPath Technologies Exhibiting at the Laser World of Photonics Show Accesswire
May-25-17 12:43PM  ETFs with exposure to LightPath Technologies, Inc. : May 25, 2017 Capital Cube
May-24-17 09:30AM  Zacks.com featured highlights: Anavex Life Sciences, Kinross Gold, LightPath Technologies, MFA Financial and Student Transportation Zacks +5.90%
May-23-17 05:15PM  Explosive Stocks Under $10 Zacks
09:10AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q3, 2017 By the Numbers : May 23, 2017 Capital Cube
May-18-17 09:30AM  The Zacks Analyst Blog Highlights: Applied Optoelectronics, MKS Instruments, Ultra Clean Holdings, Ichor Holdings and LightPath Technologies Zacks
09:00AM  LightPath Technologies Joins the Center of Freeform Optics Accesswire
May-05-17 01:00PM  LightPath Technologies Schedules 2018 Annual Stockholders' Meeting Accesswire -8.56%
May-04-17 04:00PM  LightPath Technologies Reports 500% Increase in Operating Income for Fiscal 2017 Third Quarter Financial Results Accesswire
09:45AM  Investor Network: LightPath Technologies, Inc. to Host Earnings Call Accesswire
Apr-26-17 11:05AM  LightPath Technologies Schedules Fiscal 2017 Third Quarter Financial Results Conference Call for May 4 Accesswire
Apr-24-17 02:35PM  ETFs with exposure to LightPath Technologies, Inc. : April 24, 2017 Capital Cube
Apr-20-17 09:00AM  LightPath Technologies Signs Joint Development Agreement to Produce Fiber Delivery Systems for Autonomous Vehicle Applications with OLE Accesswire +10.04%
Apr-06-17 09:00AM  LightPath Technologies Wins Large Precision Molded Glass Optics Contract from Renishaw Accesswire
Mar-30-17 11:37AM  LightPath Technologies, Inc.: Leads amongst peers with strong fundamentals Capital Cube +14.89%
09:00AM  LightPath Technologies Introduces Chalcogenide Glass Production Accesswire
Mar-09-17 09:00AM  LightPath Technologies to Exhibit at the Upcoming SPIE Defense and Commercial Sensing Event Accesswire
Mar-08-17 01:35PM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q2, 2017 By the Numbers : March 8, 2017 Capital Cube
Feb-23-17 08:30AM  LightPath Technologies to Present at 29th Annual ROTH Conference Accesswire
Feb-18-17 01:04PM  LIGHTPATH TECHNOLOGIES INC Financials
Feb-15-17 11:47AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition -5.45%
07:09AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
Feb-14-17 03:26PM  LightPath Technologies Reports 119% Increase in Operating Income for Fiscal 2017 Second Quarter Financial Results Accesswire +27.54%
Feb-06-17 11:00AM  LightPath Technologies Schedules Fiscal 2017 Second Quarter Financial Results Conference Call for February 14 Accesswire
Jan-30-17 06:03AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Dis
Jan-17-17 03:59PM  Weekly CFO Buys Highlights GuruFocus.com
Jan-10-17 06:26AM  Coverage initiated on LightPath by Dougherty & Company
Jan-05-17 06:00AM  Avidbank Expands LightPath Technologies Credit Facilities with a $5 Million Acquisition Term Loan Business Wire
Jan-01-17 06:28PM  Weekly CFO Buys Highlight GuruFocus.com
Dec-28-16 03:24PM  LightPath Technologies, Inc.: Gathering momentum, can it sustain its performance? Capital Cube
Dec-27-16 04:30PM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition +11.03%
Dec-22-16 01:44PM  ETFs with exposure to LightPath Technologies, Inc. : December 22, 2016 +9.23%
Dec-21-16 02:07PM  LightPath Technologies Completes Acquisition of ISP Optics Corporation Marketwired
Dec-20-16 04:38PM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St
Dec-16-16 08:45AM  LightPath Technologies Prices Underwritten Public Offering of Class A Common Stock Marketwired +6.56%
Dec-07-16 09:01AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Dis
08:30AM  LightPath Technologies Announces Results of Special Meeting of Stockholders Marketwired
Dec-06-16 12:35PM  ETFs with exposure to LightPath Technologies, Inc. : December 6, 2016
Nov-21-16 11:37AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q1, 2017 By the Numbers : November 21, 2016
Nov-14-16 04:04PM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:01PM  LightPath Technologies Reports Fiscal 2017 First Quarter Financial Results Marketwired
07:07AM  Q1 2017 LightPath Technologies Inc Earnings Release - After Market Close
Nov-08-16 08:30AM  LightPath Technologies Schedules Fiscal 2017 First Quarter Financial Results Conference Call for November 14 Marketwired
Nov-03-16 12:15PM  ETFs with exposure to LightPath Technologies, Inc. : November 3, 2016
Oct-20-16 09:00AM  LightPath Technologies Selected as a Recommended Lens Supplier for ULIS Micro80 Gen2(TM) Thermal Sensor Array Marketwired
Oct-14-16 10:57AM  ETFs with exposure to LightPath Technologies, Inc. : October 14, 2016
Oct-04-16 09:13AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q4, 2016 By the Numbers : October 4, 2016
Oct-03-16 11:03AM  ETFs with exposure to LightPath Technologies, Inc. : October 3, 2016
Sep-21-16 01:04PM  LIGHTPATH TECHNOLOGIES INC Financials
Sep-19-16 10:21AM  ETFs with exposure to LightPath Technologies, Inc. : September 19, 2016
09:00AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: 2016 By the Numbers : September 19, 2016
Sep-16-16 07:30PM  Edited Transcript of LPTH earnings conference call or presentation 15-Sep-16 8:30pm GMT
LightPath Technologies, Inc. designs, develops, manufactures, and distributes optical components and assemblies. The company offers precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, GRADIUM glass lenses, and other optical materials used to produce products that manipulate light. Its products are used in various industries, including defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, and other industries. The company sells its products directly to customers in North America, Europe, and China, as well as through distributors and channel partners in the United States and internationally. LightPath Technologies, Inc. was founded in 1985 and is headquartered in Orlando, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GAYNOR JOSEPH J JRPresident and CEOJan 22Option Exercise2.1030,00063,000135,987Jan 22 10:24 AM
RIPP ROBERTDirectorDec 27Option Exercise1.8630,00055,800723,751Dec 28 11:14 AM
GAYNOR JOSEPH J JRPresident and CEONov 06Option Exercise3.0515,00045,750107,709Nov 07 10:35 AM
VSTM Verastem, Inc. daily Stock Chart
VSTM [NASD]
Verastem, Inc.
Index- P/E- EPS (ttm)-1.64 Insider Own0.30% Shs Outstand41.90M Perf Week-0.91%
Market Cap137.01M Forward P/E- EPS next Y-1.58 Insider Trans92.90% Shs Float38.80M Perf Month-6.30%
Income-61.20M PEG- EPS next Q-0.43 Inst Own49.60% Short Float3.94% Perf Quarter-9.67%
Sales- P/S- EPS this Y38.80% Inst Trans13.14% Short Ratio1.54 Perf Half Y-1.51%
Book/sh1.09 P/B3.00 EPS next Y9.20% ROA-86.00% Target Price11.80 Perf Year170.25%
Cash/sh1.44 P/C2.27 EPS next 5Y1.74% ROE-110.30% 52W Range1.11 - 5.71 Perf YTD6.51%
Dividend- P/FCF- EPS past 5Y-7.80% ROI- 52W High-42.73% Beta2.19
Dividend %- Quick Ratio3.10 Sales past 5Y- Gross Margin- 52W Low194.59% ATR0.20
Employees32 Current Ratio3.10 Sales Q/Q- Oper. Margin- RSI (14)50.06 Volatility4.77% 6.99%
OptionableYes Debt/Eq0.06 EPS Q/Q-187.00% Profit Margin- Rel Volume0.56 Prev Close3.18
ShortableYes LT Debt/Eq0.06 EarningsMar 22 AMC Payout- Avg Volume989.82K Price3.27
Recom2.00 SMA20-2.58% SMA50-0.03% SMA200-4.60% Volume553,347 Change2.83%
Sep-07-17Reiterated H.C. Wainwright Buy $6.50 → $10
Apr-13-17Initiated Oppenheimer Outperform
Mar-24-17Reiterated H.C. Wainwright Buy $5 → $6.50
Sep-29-15Downgrade Raymond James Strong Buy → Outperform
Sep-29-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-29-15Downgrade Jefferies Buy → Hold
Sep-29-15Downgrade Cantor Fitzgerald Buy → Hold
Sep-28-15Downgrade ROTH Capital Buy → Neutral $23 → $2
Sep-28-15Downgrade Mizuho Buy → Neutral $21 → $2
Sep-09-15Initiated Raymond James Strong Buy
May-12-15Reiterated UBS Buy $30 → $24
Apr-08-15Initiated H.C. Wainwright Buy $16
Jan-23-15Reiterated ROTH Capital Buy $29 → $23
Jul-08-14Resumed Oppenheimer Perform
Feb-11-14Initiated Mizuho Buy $21
Aug-07-13Reiterated UBS Buy $20 → $30
Jul-12-13Reiterated Oppenheimer Outperform $16 → $18
Jul-09-13Initiated Cantor Fitzgerald Buy $22
Mar-07-12Initiated Oppenheimer Outperform $16
Feb-09-18 07:35AM  Research Report Identifies Ichor, TASER International, Premier, NuVasive, Verastem, and BLACKLINE INC with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
07:10AM  Blog Exposure - Verastem Reported Submission of NDA For Duvelisib for Treatment of Patients with Relapsed or Refractory CLL/SLL and Follicular Lymphoma ACCESSWIRE
Feb-07-18 08:30AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:00AM  Verastem Submits New Drug Application to U.S. FDA for Duvelisib for the Treatment of Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma Business Wire
Feb-06-18 04:05PM  Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jan-26-18 02:45PM  Verastem Presents Preclinical Data at ASCO-SITC Highlighting the Synergistic Effects of Duvelisib in Combination with Immune Checkpoint or Co-Stimulatory Antibodies in B Cell Lymphoma Model Business Wire +5.26%
Jan-04-18 04:01PM  Verastem Announces Increased Hercules Debt Facility Business Wire
07:01AM  Verastem Appoints Joseph Lobacki as Chief Commercial Officer Business Wire
Dec-15-17 09:18AM  Verastem Announces Pricing of Public Offering of Common Stock Business Wire -13.97%
07:00AM  3 Stocks to Watch on Friday: DDR Corp (DDR), Hess Corp. (HES) and Verastem Inc (VSTM) InvestorPlace
Dec-14-17 05:07PM  Verastem Announces Public Offering of Common Stock Business Wire
Dec-12-17 08:20AM  Todays Research Reports on Trending Tickers: Array BioPharma and Verastem, Inc. ACCESSWIRE
Dec-11-17 05:00PM  Verastem Announces the Presentation of Phase 1 Duvelisib Combination Data in T-Cell Lymphomas at the ASH 2017 Annual Meeting Business Wire -16.86%
12:07PM  2 Biotech Stocks to Have On Your Radar Into the New Year ACCESSWIRE
07:35AM  Verastem Jumps on Leukemia Drug Study Results Investopedia
Dec-10-17 04:30PM  Verastem Announces Clinical Data from the Pivotal Phase 3 DUO Study: Duvelisib Significantly Improves Progression Free Survival in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Business Wire
Dec-05-17 07:00AM  Verastem to Present Results from Pivotal Phase 3 DUO Study in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at a Research and Development Event at ASH 2017 Business Wire
Nov-20-17 08:39AM  Options Traders Expect Huge Moves in Verastem (VSTM) Stock Zacks +5.54%
07:55AM  Research Report Identifies Hill-Rom, TASER International, Synchronoss Technologies, NuVasive, Verastem, and Roku with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-08-17 07:00AM  Verastem to Present at Upcoming Investor Conferences Business Wire
Nov-07-17 07:05AM  Verastem reports 3Q loss Associated Press -5.07%
07:00AM  Verastem Reports Third Quarter 2017 Financial Results Business Wire
Nov-02-17 07:30AM  Corporate News Blog - Verastem Announces Plans to Submit NDA Requesting Full Approval of Duvelisib for Treatment of Patients with Relapsed or Refractory CLL/SLL ACCESSWIRE
Nov-01-17 09:25AM  Verastem Announces Data from Phase 3 DUO Study Selected for Oral Presentation at the American Society of Hematology 2017 Annual Meeting Business Wire -9.16%
Oct-31-17 07:00AM  Verastem Announces Regulatory Strategy for Duvelisib New Drug Application Following Guidance from FDA Business Wire
Oct-17-17 07:00AM  Verastem Pays Milestone Payment to Infinity Pharmaceuticals Business Wire
Oct-11-17 04:01PM  Verastem Appoints NgocDiep Le, MD, PhD as Chief Medical Officer Business Wire
Sep-22-17 07:15AM  Verastem to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire
Sep-07-17 08:00AM  Today's Research Reports on Stocks to Watch: Moleculin Biotech and Verastem ACCESSWIRE
Sep-06-17 11:11AM  Verastem Shares Are Exploding 50% -- Here's Why TheStreet.com +28.13%
10:31AM  Verastem's blood cancer drug succeeds in late-stage trial Reuters
06:15AM  Verastem's blood cancer drug succeeds in late-stage trial Reuters
06:05AM  Verastem Expands Duvelisib Development Program to Include Peripheral T-Cell Lymphoma Business Wire
06:01AM  Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO Study in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Business Wire
Aug-18-17 09:00AM  Implied Volatility Surging for Verastem (VSTM) Stock Options Zacks
Aug-08-17 04:05PM  Verastem Reports Second Quarter 2017 Financial Results Business Wire
Jul-25-17 07:00AM  Verastem Publishes Scientific Data Highlighting Potential Role of FAK Inhibition in Pancreatic and Breast Cancer Business Wire
Jul-13-17 08:10AM  Today's Research Reports on Stocks to Watch: Alder BioPharmaceuticals Inc. and Verastem Inc. Accesswire
Jul-11-17 04:05PM  Verastem Names Julie B. Feder as Chief Financial Officer Business Wire +16.23%
Jul-07-17 08:20AM  Verastem (VSTM) Shows Strength: Stock Adds 42% in Session Zacks
Jun-24-17 10:00AM  Verastem Reports Phase 2 Long-Term Follow-Up Data for Duvelisib in Patients with Double-Refractory Follicular Lymphoma and Small Lymphocytic Lymphoma at the 22nd Congress of the European Hematology Association Business Wire
Jun-07-17 04:05PM  Verastem to Present Long-Term Follow-Up Data from the DYNAMO Study at the 14th International Conference on Malignant Lymphoma Business Wire
Jun-05-17 01:48PM  Notes From ASCO 2017: Tesaro, Amgen, Others Report New Data Benzinga
May-31-17 07:00AM  Verastem to Present at the Jefferies 2017 Global Healthcare Conference Business Wire -11.97%
May-18-17 06:44AM  Verastem Announces Duvelisib Data Presentations at the 22nd Congress of the European Hematology Association Business Wire
May-11-17 08:00AM  Today's Research Reports on Stocks to Watch: Array Biopharma and Verastem Accesswire
May-10-17 05:18PM  Verastem reports 1Q loss Associated Press +18.45%
04:05PM  Verastem Reports First Quarter 2017 Financial Results Business Wire
09:00AM  BioXcel Therapeutics, Inc. (BTI) Is Launched with Phase 2-ready Programs Addressing Unmet Needs in Immuno-oncology and Neuroscience GlobeNewswire
May-03-17 07:00AM  Verastem Announces Long Term Follow-up Data from the DYNAMO Study Selected for Oral Presentation at the 14th International Conference on Malignant Lymphoma Business Wire
May-02-17 07:00AM  Verastem Appoints Eric K. Rowinsky to the Board of Directors Business Wire
Apr-17-17 07:30AM  Today's Research Reports on Biotech Stocks to Watch: Ocera Therapeutics and Verastem Accesswire +13.51%
Apr-03-17 07:00AM  Verastem to Present at the 16th Annual Needham Healthcare Conference Business Wire
Apr-02-17 02:05PM  Data on Verastems Focal Adhesion Kinase Inhibitor Defactinib Presented at the 2017 American Association for Cancer Research Annual Meeting Business Wire
Mar-29-17 01:04PM  VERASTEM, INC. Financials +7.89%
Mar-24-17 12:51PM  Edited Transcript of VSTM earnings conference call or presentation 23-Mar-17 8:30pm GMT +9.93%
Mar-23-17 04:30PM  Verastem Inc Earnings Call scheduled for 4:30 pm ET today
04:25PM  VERASTEM, INC. Files SEC form 10-K, Annual Report
04:01PM  Verastem Reports Year-End 2016 Financial Results Business Wire
Mar-16-17 07:00AM  Verastem to Host Conference Call on March 23rd to Discuss Fourth Quarter and Full-Year 2016 Financial Results and Recent Highlights Business Wire
Mar-15-17 04:05PM  Verastem to Present at the Oppenheimer 27th Annual Healthcare Conference Business Wire +5.11%
Mar-07-17 07:00AM  Verastem to Present at the 29th Annual ROTH Conference Business Wire
Feb-07-17 07:00AM  Verastem to Present at 19th Annual BIO CEO & Investor Conference Business Wire
Jan-26-17 07:00AM  Verastem Announces Dosing of First Patient in Combination Trial of Defactinib and Avelumab in Patients with Ovarian Cancer Business Wire
Jan-19-17 04:28PM  Verastem Announces Executive Leadership Appointments and Changes Business Wire
12:29PM  Verastem's CEO Talks DYNAMO Study, The Competitive Landscape And Pitch To Investors
Jan-11-17 04:34PM  VERASTEM, INC. Files SEC form 8-K/A, Other Events
Jan-09-17 06:00AM  Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan GlobeNewswire
Dec-05-16 09:15PM  Verastem Presents Phase 2 DYNAMO® Clinical Data at ASH 2016 Annual Meeting Business Wire
Nov-11-16 03:06PM  Infinity (INFI) Reports Narrower-than-Expected Loss in Q3
Nov-07-16 05:42PM  Verastem reports 3Q loss
05:00PM  VERASTEM, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  Verastem Reports Third Quarter 2016 Financial Results Business Wire
Nov-03-16 09:13AM  Verastem Announces Presentations at ASH Annual Meeting Business Wire -6.61%
Nov-02-16 07:25AM  VERASTEM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositi
06:45AM  Verastem Licenses Duvelisib from Infinity Pharmaceuticals PR Newswire
Oct-06-16 07:20PM  HC Wainwright Issues $5 Target for Verastem (VSTM) at Investopedia +7.19%
Sep-30-16 05:00AM  Cancer Research UK, MSD and Verastem Collaborate to Trial New Combination of Immunotherapy Drugs Business Wire
Sep-06-16 07:00AM  Verastem to Present at Rodman & Renshaw 18th Annual Global Investment Conference Business Wire
Aug-08-16 09:05AM  VERASTEM, INC. Files SEC form 10-Q, Quarterly Report
08:46AM  Verastem reports 2Q loss
08:40AM  Verastem Reports Second Quarter 2016 Financial Results Business Wire
Jul-06-16 07:00AM  Verastem to Present at Cantor Fitzgeralds 2nd Annual Healthcare Conference Business Wire
Jul-05-16 08:20AM  Study Published in Nature Medicine Highlights Potential Role of FAK Inhibition in Pancreatic Cancer Business Wire
Jun-14-16 04:12PM  VERASTEM, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:05PM  Verastem Announces Changes to its Board of Directors Business Wire
Jun-10-16 05:00PM  Verastem, Inc. :VSTM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016
Jun-01-16 07:00AM  Verastem to Present at Upcoming Investor Conferences Business Wire
May-16-16 01:03PM  VERASTEM, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-09-16 05:24PM  Verastem reports 1Q loss
05:23PM  VERASTEM, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  Verastem Reports First Quarter 2016 Financial Results Business Wire
May-03-16 09:15AM  Verastem Announces the Presentation of Clinical Data at iMig 2016 Business Wire
Apr-26-16 08:26AM  4 Trending Small Cap Stocks That You Need To Watch Today Accesswire -8.60%
Apr-25-16 08:25AM  8 Breakout Stocks Under $10 to Trade for Big Profits at TheStreet +17.72%
Apr-18-16 05:31PM  VERASTEM, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
05:20PM  Verastem Names Gregory I. Berk, MD as Chief Medical Officer Business Wire
07:00AM  Verastem Co-Founder, Dr. Robert Weinberg, Recognized with Two Prestigious Cancer Research Awards Business Wire
Mar-30-16 04:05PM  Verastem Announces Presentation of Scientific Data Supporting FAK Inhibition in Combination with Immunotherapy at the Keystone Symposium on Cancer Pathophysiology Business Wire
Mar-22-16 04:19PM  Verastem Announces Oral Presentation of Data Supporting the Preferential Targeting of Ovarian Cancer Stem Cells at the Society of Gynecologic Oncologys 2016 Annual Meeting on Womens Cancer at noodls
Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma. The company's duvelisib is in Phase 3 randomized and two-arm trial for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, as well as completed the Phase 2 study for the treatment of patients with refractory indolent non-Hodgkin lymphoma. The company has license agreement with Infinity Pharmaceuticals, Inc.; The Scripps Research Institute; and Pfizer, Inc. Verastem, Inc. was founded in 2010 and is headquartered in Needham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARBERICH TIMOTHY JDirectorDec 05Buy3.9560,538239,125130,000Dec 07 04:02 PM
BARBERICH TIMOTHY JDirectorMay 15Buy2.4530,00073,50069,462May 17 08:21 AM
HPJ Highpower International, Inc. daily Stock Chart
HPJ [NASD]
Highpower International, Inc.
Index- P/E4.00 EPS (ttm)0.89 Insider Own28.50% Shs Outstand15.50M Perf Week-5.33%
Market Cap55.02M Forward P/E- EPS next Y- Insider Trans-12.29% Shs Float10.36M Perf Month-13.41%
Income13.70M PEG- EPS next Q- Inst Own14.50% Short Float1.17% Perf Quarter-12.35%
Sales218.90M P/S0.25 EPS this Y60.50% Inst Trans27.66% Short Ratio2.01 Perf Half Y-26.04%
Book/sh3.93 P/B0.90 EPS next Y- ROA7.50% Target Price12.86 Perf Year42.00%
Cash/sh0.77 P/C4.62 EPS next 5Y- ROE26.50% 52W Range2.36 - 6.00 Perf YTD-4.05%
Dividend- P/FCF- EPS past 5Y33.50% ROI4.40% 52W High-40.83% Beta2.33
Dividend %- Quick Ratio0.80 Sales past 5Y9.50% Gross Margin21.20% 52W Low50.74% ATR0.19
Employees3950 Current Ratio1.00 Sales Q/Q32.00% Oper. Margin6.40% RSI (14)39.52 Volatility5.99% 5.29%
OptionableYes Debt/Eq1.12 EPS Q/Q79.90% Profit Margin6.30% Rel Volume0.61 Prev Close3.65
ShortableYes LT Debt/Eq0.00 EarningsMar 27 BMO Payout0.00% Avg Volume60.37K Price3.55
Recom- SMA20-8.57% SMA50-9.57% SMA200-19.78% Volume36,683 Change-2.74%
Sep-29-14Reiterated H.C. Wainwright Buy $8 → $12
Sep-23-14Initiated Ardour Capital Buy $15
May-13-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $4
Mar-31-10Reiterated Rodman & Renshaw Mkt Outperform $5 → $7
Aug-17-09Initiated Rodman & Renshaw Mkt Outperform $5
Dec-28-17 08:30AM  Highpower International to Attend CES 2018 PR Newswire
Dec-15-17 08:30AM  Highpower International Announces Signing of USD $14.2 Million Investment to Ganzhou Highpower PR Newswire
Dec-05-17 08:30AM  Highpower International to Participate in the 5th Annual ROTH Industrial Growth and Cleantech 1x1 Event in New York PR Newswire
Nov-14-17 06:50AM  Highpower International, Inc. to Host Earnings Call ACCESSWIRE -12.27%
06:29AM  Does Highpower International Incs (HPJ) PE Ratio Warrant A Buy? Simply Wall St.
06:00AM  Highpower International Reports Unaudited Third Quarter, First Nine Months 2017 Financial Results PR Newswire
Nov-02-17 08:30AM  Highpower International to Announce Third Quarter 2017 Financial Results PR Newswire
Oct-18-17 08:30AM  Highpower International Announces New Independent Director PR Newswire +5.43%
Oct-10-17 09:20AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q2, 2017 By the Numbers : October 10, 2017 Capital Cube +6.93%
Sep-13-17 08:30AM  Highpower International Adopts Stockholder Rights Plan PR Newswire
Sep-05-17 08:30AM  Highpower International to Present at the Rodman & Renshaw 19th Annual Global Investment Conference PR Newswire
Aug-10-17 08:30AM  Investor Network: Highpower International, Inc. to Host Earnings Call ACCESSWIRE -5.05%
06:00AM  Highpower International Reports Unaudited Second Quarter First Half 2017 Financial Results PR Newswire
Aug-07-17 08:30AM  Highpower International to Announce Second Quarter 2017 Financial Results PR Newswire +5.43%
Jul-28-17 08:30AM  Highpower International Receives $10.5 Million from Yipeng Shares Transfer and Enters Strategic Power Cell Supply Agreement with Yipeng PR Newswire
Jul-19-17 04:05PM  Highpower International Announces Preliminary Unaudited Second Quarter 2017 Results PR Newswire
Jul-14-17 08:00AM  Highpower International Enters Smart Vacuum Market with Two New Partnerships PR Newswire +11.59%
Jun-22-17 03:01PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q1, 2017 By the Numbers : June 22, 2017 Capital Cube
Jun-15-17 05:04PM  Highpower International Announces Management Changes PR Newswire +6.67%
Jun-02-17 08:00AM  Highpower International to Present at the 2017 Marcum Microcap Conference PR Newswire
May-10-17 08:45AM  Investor Network: Highpower International, Inc. to Host Earnings Call Accesswire
06:00AM  Highpower International Reports Unaudited First Quarter 2017 Financial Results PR Newswire
May-05-17 08:00AM  Highpower International Enters into Equity Transfer Agreement PR Newswire
May-02-17 08:00AM  Highpower International to Announce First Quarter 2017 Financial Results PR Newswire
Apr-18-17 08:00AM  Highpower International to Attend the SNEC 11th (2017) International Photovoltaic Power Generation Conference & Exhibition PR Newswire +8.74%
Apr-11-17 01:35PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q4, 2016 By the Numbers : April 11, 2017 Capital Cube
10:45AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: 2016 By the Numbers : April 11, 2017 Capital Cube
08:00AM  Highpower International Retains ICR, Inc. PR Newswire
Apr-06-17 03:44PM  6 Stocks Trading Below Peter Lynch Value GuruFocus.com +14.29%
Apr-01-17 01:04PM  HIGHPOWER INTERNATIONAL, INC. Financials
Mar-28-17 09:59AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo +30.67%
07:00AM  Highpower International Reports Record Financial Results For the Fourth Quarter and Year End December 31, 2016 PR Newswire
Mar-10-17 05:09PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure
Mar-07-17 02:50PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo +6.00%
08:00AM  Highpower International Announces Preliminary Unaudited 2016 Fourth Quarter and Year End Financial Results Highlighted by Significantly Improved Revenues and Net Income PR Newswire
Feb-27-17 08:00AM  Highpower International to Present at the 29th Annual ROTH Growth Conference on March 14, 2017 PR Newswire
Feb-15-17 03:06PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
08:00AM  Highpower International Appointment of Mr. Sunny Pan as Chief Financial Officer Mr. Pan Has Served as Interim CFO since August 2016 PR Newswire
Dec-21-16 02:33PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-14-16 11:49AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Capital Cube
11:49AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
Nov-10-16 09:01AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
Nov-09-16 04:05PM  Highpower International Reports Financial Results For the Third Quarter and Nine Months Ended September 30, 2016 PR Newswire
07:07AM  Q3 2016 Highpower International Inc Earnings Release - After Market Close
Nov-07-16 07:00AM  Highpower International Schedules 2016 Third Quarter Financial Results and Conference Call on November 10, 2016 PR Newswire
Sep-01-16 11:04AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +19.11%
Aug-16-16 10:00AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 Capital Cube
10:00AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
Aug-15-16 05:30PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
Aug-12-16 07:31AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo +5.24%
07:07AM  Q2 2016 Highpower International Inc Earnings Release - Before Market Open
07:01AM  Highpower International Enters Into Equity Purchase Agreement PR Newswire
07:00AM  Highpower International Reports Financial Results For the Second Quarter And Six Months Ended June 30, 2016 PR Newswire
Aug-09-16 04:29PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
04:05PM  Highpower International Announces Chief Financial Officer Transition PR Newswire
Aug-02-16 08:30AM  Highpower International Schedules 2016 Second Quarter Financial Results and Conference Call on August 12, 2016 PR Newswire
Jul-29-16 08:30AM  Highpower Announces Shipment of Portable Power Stations to Fry's Electronics; Available in Stores in September 2016 PR Newswire
Jun-16-16 08:30AM  Highpower International to Attend Electric Energy Storage Europe on June 22 -24, 2016 PR Newswire
Jun-01-16 12:15PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-16-16 12:55PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
May-12-16 09:46AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
08:30AM  Highpower International Reports Financial Results For the First Quarter Ended March 31, 2016 PR Newswire
07:07AM  Q1 2016 Highpower International Inc Earnings Release - Before Market Open
May-06-16 08:30AM  Highpower International Schedules 2016 First Quarter Financial Results and Conference Call on May 12, 2016 PR Newswire
Apr-12-16 12:04PM  Top Penny Stocks: Four Trending Small Cap Stocks on Tuesday April 12 Accesswire +19.90%
11:55AM  Heres Why These 5 Stocks Are on the Move Today at Insider Monkey
10:49AM  Recent Analyst Ratings and Fundamental Analysis (NASDAQ: HPJ) Accesswire
10:44AM  Top 4 Stocks The We've Been Watching This Month Accesswire
08:30AM  Highpower International Starts Shipments of Lithium Polymer Batteries to DJI for Use on Its Drone Products PR Newswire
Mar-29-16 05:11PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 10-K, Annual Report
01:22PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-24-16 08:16AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo -18.30%
08:00AM  Highpower International Reports Financial Results for the Fiscal Fourth Quarter and Year Ended December 31, 2015 PR Newswire
07:07AM  Q4 2015 Highpower International Inc Earnings Release - Before Market Open
Mar-15-16 08:30AM  Highpower International Schedules 2015 Fourth Quarter and Year-End Financial Results and Conference Call on March 24, 2016 PR Newswire
Jan-11-16 08:30AM  Highpower Special Committee Engages Financial Advisor and Legal Counsel PR Newswire
Jan-05-16 08:30AM  Highpower to Exhibit at 2016 International CES in Las Vegas on January 6-9, 2016 PR Newswire
Dec-11-15 10:47AM  Highpower International, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-03-15 05:30PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-30-15 10:10AM  Company News for November 30, 2015
06:01AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-27-15 11:57AM  These 4 Stocks Are Strong Gainers On Friday at Insider Monkey
08:30AM  Highpower International Announces Receipt of Non-binding Investment Proposal PR Newswire
Nov-16-15 08:30AM  Highpower International to Participate in the Fourth China-Germany Joint Working Group Meeting on Electric Vehicle Battery Recycling PR Newswire
Nov-12-15 08:31AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
08:00AM  Highpower International Reports Financial Results For the Third Quarter and Nine Months Ended September 30, 2015 PR Newswire
Nov-02-15 08:30AM  Highpower International To Hold Annual Shareholder Meeting on November 28, 2015 PR Newswire
Sep-21-15 11:27AM  Highpower International, Inc. Earnings Q2, 2015
Sep-01-15 08:00AM  MicroCap Review Magazine Summer/Fall 2015 Issue Now Available Marketwired
Aug-31-15 08:30AM  Highpower International to Present at Investor Conferences in September in New York PR Newswire
Aug-10-15 08:03AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
08:00AM  Highpower International Reports Financial Results For the Second Quarter And Six Months Ended June 30, 2015 PR Newswire
Jul-30-15 08:30AM  Highpower International Schedules 2015 Second Quarter Financial Results and Conference Call on August 10, 2015 PR Newswire
Jul-09-15 08:30AM  Highpower International Sponsors and Featured at Third Xueqiu Investment Carnival in Beijing PR Newswire
Jul-07-15 08:30AM  Highpower International Granted U.S. Patent for New Safety Technology PR Newswire
May-22-15 08:30AM  Highpower Receives Best Design Award at the 5th China International Energy Storage Conference and Exhibition PR Newswire
May-15-15 02:38PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
May-11-15 08:30AM  Highpower International to Present at B. Riley 16th Annual Investor Conference PR Newswire
May-08-15 09:01AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
08:31AM  Highpower reports 1Q loss
Highpower International, Inc. produces and sells nickel-metal hydride (Ni-MH) and lithium-based rechargeable batteries. The company operates in three segments: Lithium Batteries, Ni-MH Batteries, and New Materials. It offers Ni-MH rechargeable batteries in AA, AAA, 9V, C, D, and SC sizes in blister packing, as well as chargers and battery packs. The company also provides lithium-ion cylindrical and polymer rechargeable batteries, and power source solutions. In addition, it is involved in recycling scrap battery materials and sells the recycled materials; the processing, marketing, and research of battery materials; and the design and production of battery packs and systems. The company's products are used in various applications, such as electric buses, bikes, energy storage systems, power tools, medical equipment, digital and electronic devices, personal care products, lighting, etc. It sells its products in the People's Republic of China, rest of Asia, Europe, North America, South America, Africa, and internationally. The company was formerly known as Hong Kong Highpower Technology, Inc. and changed its name to Highpower International, Inc. in October 2010. Highpower International, Inc. was founded in 2001 and is headquartered in Shenzhen, the People's Republic of China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Li PingDirectorNov 28Sale4.4310,50046,51215,000Nov 30 06:57 PM
LI WEN LIANGDirectorNov 01Sale5.2965,000343,9481,501,117Nov 02 08:46 PM
LI WEN LIANGDirectorOct 31Sale5.793,37019,5171,566,117Nov 02 08:46 PM
LI WEN LIANGDirectorOct 30Sale5.7733,225191,6191,569,487Oct 30 08:32 PM
LI WEN LIANGDirectorOct 27Sale5.758,88151,0711,602,712Oct 30 08:32 PM
LI WEN LIANGDirectorOct 26Sale5.7738,152220,0231,611,593Oct 30 08:32 PM
LI WEN LIANGDirectorOct 25Sale5.506,43335,3821,649,745Oct 30 08:32 PM
LI WEN LIANGDirectorOct 13Sale5.524,07022,4851,656,178Oct 17 07:04 PM
LI WEN LIANGDirectorOct 11Sale5.5289,497494,3901,660,248Oct 12 06:46 PM
LI WEN LIANGDirectorOct 10Sale5.2883,918442,9021,749,745Oct 12 06:46 PM
LI WEN LIANGDirectorOct 06Sale5.257,10737,3121,833,663Oct 10 05:07 PM
LI WEN LIANGDirectorOct 05Sale5.0166,699333,9221,840,770Oct 10 05:07 PM
LI WEN LIANGDirectorSep 21Sale5.251,8009,4501,887,469Sep 25 09:06 PM
LI WEN LIANGDirectorSep 20Sale5.1183,152424,5661,889,269Sep 20 07:14 PM
LI WEN LIANGDirectorSep 19Sale5.04117,224590,7621,972,421Sep 20 07:14 PM
LI WEN LIANGDirectorSep 18Sale5.001005002,089,645Sep 20 07:14 PM
LI WEN LIANGDirectorJun 05Sale5.1244,125225,8582,089,745Jun 06 04:06 PM
MA WEN WEIVP of ManufacturingJun 02Sale5.0029,003145,015456,367Jun 13 07:58 PM
LI WEN LIANGDirectorJun 01Sale5.001005002,133,870Jun 06 04:06 PM
MA WEN WEIVP of ManufacturingJun 01Sale5.007,96539,825485,370Jun 05 08:42 PM
MA WEN WEIVP of ManufacturingMay 19Sale5.006003,000493,335May 19 08:17 PM
MA WEN WEIVP of ManufacturingMay 17Sale5.0238,205191,808493,935May 19 08:17 PM
MA WEN WEIVP of ManufacturingMay 16Sale5.16318,7571,644,499532,140May 17 08:49 PM
MA WEN WEIVP of ManufacturingMay 15Sale5.6650,000283,220850,897May 17 08:49 PM